Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

922412

Sigma-Aldrich

EncapGel™ sustained release hydrogel for drug delivery

Sinónimos:

Drug delivery, Hydrogel, LT-GEL, TGelBio

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

UNSPSC Code:
12162002
NACRES:
NA.23

form

powder

Quality Level

100

impurities

≤0.125 EU/mg Endotoxin

color

white to off-white

Categorías relacionadas

Application

EncapGel™ sustained release drug delivery hydrogel can be used for the encapsulation and delivery of drug or cells. The solution gels rapidly at 20 °C to 36 °C. Reverse thermal property of this hydrogel allows the percutaneous injection and immediate gelation in the body. The hydrogel matrix allows the spatial control of desired therapeutic agent in the vicinity of the target area. This hydrogel matrix is biodegraded completely within 3 days in-vivo, which allows the sustained release of the therapeutic agent to the targeted area. It is a research use only product to test the safety and efficacy of various therapeutic agents, such as drugs, small bioactive molecules, proteins, exosomes, targeted administration of micro- and nano-particles encapsulating therapeutic agents, or cellular-based therapeutics. This product is in a lyophilized powder form, and each vial can make 5 mL hydrogel.

Packaging

1.025 g in a glass vial

Legal Information

ENCAPGEL is a trademark of Sigma-Aldrich Co. LLC

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Dongrim Seol et al.
Journal of biomedical materials research. Part B, Applied biomaterials, 101(8), 1508-1515 (2014-03-05)
We recently introduced a novel pluronic F127 and hyaluronic acid-based hydrogel (HG) designed to deliver a broad range of therapeutics. The reverse-thermal responsive HG exhibits physical properties that seem to be ideal for the local delivery of drug- and cell-based
Yusung Kim et al.
International journal of radiation oncology, biology, physics, 88(5), 1142-1147 (2014-02-06)
To propose a novel radiation therapy (RT) delivery modality: locally targeted delivery of micron-size RT sources by using temperature-sensitive hydrogel (RT-GEL) as an injectable vehicle. Hydrogel is a water-like liquid at room temperature but gels at body temperature. Two US
Keun Sang Oh et al.
International journal of pharmaceutics, 558, 225-230 (2019-01-18)
Postoperative pain is a common form of acute pain that has been treated commonly by local anesthetics through regional nerve blocking. In this study, a series of experiments were conducted using rats to investigate the pharmacokinetic, distribution, and efficacy of
Jin Whan Lee et al.
Journal of biomedical materials research. Part A, 92(1), 378-385 (2009-02-05)
Possible solution to the long-term control of the low back pain (LBP) would be by using an injectable pain drug carrier that can be delivered locally. The drug can be released in a controlled manner. It is also allowed to

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico